Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd and OctoPlus NV Update on Intended Public Offer of Dr. Reddy's Laboratories Ltd's for All OctoPlusNV's Shares


Thursday, 15 Nov 2012 10:46pm EST 

Dr.Reddy's Laboratories Ltd (Dr.Reddy's) and OctoPlus NV (OctoPlus) announced that they have reached conditional agreement in connection with an intended public offer by Dr.Reddy's, or a wholly owned subsidiary of Dr.Reddy's, for all issued and outstanding ordinary shares in the capital of OctoPlus at an offer price of EUR 0.52 (cum dividend) in cash (the Offer Price) for each OctoPlus share (the Offer). Dr.Reddy's and OctoPlus announced that preparations for the Offer, including preparations in respect of the offer memorandum for the Offer (the Offer Memorandum) are proceeding as planned. 

Company Quote

46.64
1.18 +2.60%
30 Jul 2014